CAS: 518048-05-0 - Raltegravir
Formula:C20H21FN6O5
InChI:InChI=1S/C20H21FN6O5/c1-10-25-26-17(32-10)16(30)24-20(2,3)19-23-13(14(28)18(31)27(19)4)15(29)22-9-11-5-7-12(21)8-6-11/h5-8,28H,9H2,1-4H3,(H,22,29)(H,24,30)
InChI key:InChIKey=CZFFBEXEKNGXKS-UHFFFAOYSA-N
SMILES:O=C(NC(C1=NC(C(=O)NCC2=CC=C(F)C=C2)=C(O)C(=O)N1C)(C)C)C3=NN=C(O3)C
- Synonyms:
- 4-Pyrimidinecarboxamide, N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-
- 5-Hydroxy-2-[1-[[(5-Methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]-1-methylethyl]-N-(4-fluorobenzyl)-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide
- N-(4-fluorobenzyl)-5-hydroxy-1-methyl-2-(1-methyl-1-{[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino}ethyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide
- N-[(4-Fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxamide
- Raltegravir
Raltegravir
CAS:518048-05-0
Formula:
C20H21FN6O5
Color and Shape:
White To Off-White Solid
Molecular weight:
444.42
Ref: 4Z-R-241
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Ref: 4Z-R-245
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Raltegravir
CAS:518048-05-0
Formula:
C20H21FN6O5
Purity:
≥ 99.0%
Color and Shape:
White to off-white crystalline powder
Molecular weight:
444.42
Ref: 7W-GP2267
Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Raltegravir
CAS:518048-05-0
Raltegravir (MK-0518) is a pyrrolidinone derivative and HIV INTEGRASE INHIBITOR that is used in combination …
Formula:
C20H21FN6O5
Purity:
100% - 99.05%
Color and Shape:
Solid
Molecular weight:
444.42
Ref: TM-T2239L
2mg | 45.00 € | ||
5mg | 63.00 € | ||
10mg | 102.00 € | ||
25mg | 179.00 € | ||
50mg | 296.00 € | ||
100mg | 440.00 € | ||
1mL*10mM (DMSO) | 64.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Ref: 4Z-R-242
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Ref: 10-F547236
1g | To inquire | ||
250mg | To inquire |
Estimated delivery in United States, on Wednesday 15 Jan 2025
Raltegravir
Controlled ProductCAS:518048-05-0
Applications Raltegravir (MK-0518) is a potent integrase (IN) inhibitor for WT and S217Q PFV IN. …
Formula:
C20H21FN6O5
Color and Shape:
Neat
Molecular weight:
444.42
Ref: TR-R100305
5mg | 192.00 € | ||
10mg | 303.00 € | ||
50mg | 519.00 € |
Estimated delivery in United States, on Wednesday 15 Jan 2025
Raltegravir - Bio-X ™
CAS:518048-05-0
Raltegravir is an antiretroviral agent used for the treatment of HIV infections in conjunction with …
Formula:
C20H21FN6O5
Purity:
Min. 98 Area-%
Color and Shape:
Powder
Molecular weight:
444.42 g/mol
Ref: 3D-BR164312
10mg | 136.00 € |
Estimated delivery in United States, on Thursday 16 Jan 2025
Raltegravir
CAS:518048-05-0
Raltegravir is an antiviral drug that is used in the treatment of HIV-1 infection. It …
Formula:
C20H21FN6O5
Purity:
Min. 98 Area-%
Color and Shape:
White Off-White Powder
Molecular weight:
444.42 g/mol
Ref: 3D-FR29048
1g | 329.00 € | ||
2g | 483.00 € | ||
100mg | 137.00 € | ||
250mg | 147.00 € | ||
500mg | 215.00 € |
Estimated delivery in United States, on Thursday 16 Jan 2025